Eversept Partners, LP Autolus Therapeutics PLC Transaction History

Eversept Partners, LP

  • $1.26 Billion
  • Q3 2024

A detailed history of Eversept Partners, LP transactions in Autolus Therapeutics PLC stock. As of the latest transaction made, Eversept Partners, LP holds 406,558 shares of AUTL stock, worth $1.25 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
406,558
Previous 610,902 33.45%
Holding current value
$1.25 Million
Previous $2.13 Million 30.59%
% of portfolio
0.12%
Previous 0.16%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$3.38 - $4.69 $690,682 - $958,373
-204,344 Reduced 33.45%
406,558 $1.48 Million
Q2 2024

Aug 14, 2024
BUY
$3.33 - $5.68 $2.03 Million - $3.47 Million
610,902 New
610,902 $2.13 Million
Q2 2022

Aug 15, 2022
SELL
$2.04 - $4.68 $757,941 - $1.74 Million
-371,540 Closed
0 $0
Q1 2022

Nov 08, 2023
BUY
$3.52 - $5.46 $1.31 Million - $2.03 Million
371,540 New
371,540 $1.55 Million
Q1 2022

May 16, 2022
SELL
$3.52 - $5.46 $105,600 - $163,800
-30,000 Reduced 7.47%
371,540 $1.55 Million
Q4 2021

Nov 08, 2023
BUY
$5.1 - $7.0 $17,676 - $24,262
3,466 Added 0.87%
401,540 $2.08 Million
Q4 2021

Feb 14, 2022
BUY
$5.1 - $7.0 $17,676 - $24,262
3,466 Added 0.87%
401,540 $2.08 Million
Q3 2021

Nov 08, 2023
SELL
$5.32 - $7.37 $399,000 - $552,750
-75,000 Reduced 15.85%
398,074 $2.61 Million
Q3 2021

Nov 15, 2021
SELL
$5.32 - $7.37 $399,000 - $552,750
-75,000 Reduced 15.85%
398,074 $2.61 Million
Q2 2021

Nov 08, 2023
BUY
$4.78 - $7.96 $1.52 Million - $2.53 Million
318,093 Added 205.25%
473,074 $3.14 Million
Q2 2021

Aug 16, 2021
BUY
$4.78 - $7.96 $2.26 Million - $3.77 Million
473,074 New
473,074 $3.14 Million
Q1 2021

May 13, 2021
SELL
$5.49 - $9.36 $850,845 - $1.45 Million
-154,981 Closed
0 $0
Q4 2020

Nov 08, 2023
BUY
$8.13 - $12.79 $1.26 Million - $1.98 Million
154,981 New
154,981 $1.39 Million
Q4 2020

Feb 16, 2021
SELL
$8.13 - $12.79 $840,471 - $1.32 Million
-103,379 Reduced 40.01%
154,981 $1.39 Million
Q2 2020

Nov 08, 2023
BUY
$5.38 - $16.14 $260,106 - $780,320
48,347 Added 23.02%
258,360 $4.14 Million
Q2 2020

Aug 13, 2020
BUY
$5.38 - $16.14 $260,106 - $780,320
48,347 Added 23.02%
258,360 $4.14 Million
Q1 2020

Nov 08, 2023
BUY
$4.2 - $13.0 $882,054 - $2.73 Million
210,013 New
210,013 $1.26 Million
Q1 2020

May 13, 2020
BUY
$4.2 - $13.0 $882,054 - $2.73 Million
210,013 New
210,013 $1.26 Million

Others Institutions Holding AUTL

# of Institutions
104
Shares Held
163M
Call Options Held
2.8K
Put Options Held
13.4K
View Full List

About Autolus Therapeutics plc

AUTL Quotes by TradingView
  • Ticker AUTL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 90,909,800
  • Market Cap $280M
  • Description
  • Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer. The company's clinical-stage programs include obecabtagene autoleucel (AUTO1), a CD19-targeting programmed T cell investigational therapy that is in Phase 1b/2 clinical trial for the treatment of adult ALL; AUTO1/22, which...
More about AUTL
Track This Portfolio

Track Eversept Partners, LP Portfolio

Follow Eversept Partners, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eversept Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Eversept Partners, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email